Acceder

Publicaciones - HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL

Cargando...
Rivera-Caravaca JM, Marin F, Esteve-Pastor MA, Galvez J, Lip GYH, Vicente V, Roldan V. Murcia atrial fibrillation project II: protocol for a prospective observational study in patients with atrial fibrillation. BMJ Open. 2019 Dec 15;9(12):e033712. doi: 10.1136/bmjopen-2019-033712. Erratum In: BMJ Open. 2022 Dec 22;12(12):e033712corr1. PubMed PMID: 31843852; PubMed Central PMCID: PMC6924708.
AÑO: 2019; IF: 3.006
Coscolin C, Katzke N, Garcia-Moyano A, Navarro-Fernandez J, Almendral D, Martinez-Martinez M, Bollinger A, Bargiela R, Gertler C, Chernikova TN, Rojo D, Barbas C, Tran H, Golyshina OV, Koch R, Yakimov MM, Bjerga GEK, Golyshin PN, Jaeger KE, Ferrer M. Bioprospecting Reveals Class III omega-Transaminases Converting Bulky Ketones and Environmentally Relevant Polyamines. Appl Environ Microbiol. 2019 Jan 9;85(2):e02404-18. doi: 10.1128/AEM.02404-18. Print 2019 Jan 15. PubMed PMID: 30413473; PubMed Central PMCID: PMC6328768.
AÑO: 2019; IF: 5.005
Pertesi M, Vallee M, Wei X, Revuelta MV, Galia P, Demangel D, Oliver J, Foll M, Chen S, Perrial E, Garderet L, Corre J, Leleu X, Boyle EM, Decaux O, Rodon P, Kolb B, Slama B, Mineur P, Voog E, Le Bris C, Fontan J, Maigre M, Beaumont M, Azais I, Sobol H, Vignon M, Royer B, Perrot A, Fuzibet JG, Dorvaux V, Anglaret B, Cony-Makhoul P, Berthou C, Desquesnes F, Pegourie B, Leyvraz S, Mosser L, Frenkiel N, Augeul-Meunier K, Leduc I, Leyronnas C, Voillat L, Casassus P, Mathiot C, Cheron N, Paubelle E, Moreau P, Bignon YJ, Joly B, Bourquard P, Caillot D, Naman H, Rigaudeau S, Marit G, Macro M, Lambrecht I, Cliquennois M, Vincent L, Helias P, Avet-Loiseau H, Moreno V, Reis RM, Varkonyi J, Kruszewski M, Vangsted AJ, Jurczyszyn A, Zaucha JM, Sainz J, Krawczyk-Kulis M, Watek M, Pelosini M, Iskierka-Jazdzewska E, Grzasko N, Martinez-Lopez J, Jerez A, Campa D, Buda G, Lesueur F, Dudzinski M, Garcia-Sanz R, Nagler A, Rymko M, Jamroziak K, Butrym A, Canzian F, Obazee O, Nilsson B, Klein RJ, Lipkin SM, McKay JD, Dumontet C. Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma. Leukemia. 2019 Sep;33(9):2324-2330. doi: 10.1038/s41375-019-0452-6. Epub 2019 Apr 9. No abstract available. PubMed PMID: 30967618; PubMed Central PMCID: PMC6756025.
AÑO: 2019; IF: 8.665
Rodriguez-Otero P, Mateos MV, Martinez-Lopez J, Hernandez MT, Ocio EM, Rosinol L, Martinez R, Teruel AI, Gutierrez NC, Bargay J, Bengoechea E, Gonzalez Y, de Oteyza JP, Gironella M, Nunez-Cordoba JM, Encinas C, Martin J, Cabrera C, Palomera L, de Arriba F, Cedena MT, Puig N, Oriol A, Paiva B, Blade J, Lahuerta JJ, San Miguel JF. Predicting long-term disease control in transplant-ineligible patients with multiple myeloma: impact of an MGUS-like signature. Blood Cancer J. 2019 Mar 18;9(4):36. doi: 10.1038/s41408-019-0176-x. PubMed PMID: 30886139; PubMed Central PMCID: PMC6423121.
AÑO: 2019; IF: 8.023
Garcia Garcia Y, de Juan Ferre A, Mendiola C, Barretina-Ginesta MP, Gaba Garcia L, Santaballa Bertran A, Bover Barcelo I, Gil-Martin M, Manzano A, Rubio Perez MJ, Romeo Marin M, Arqueros Nunez C, Garcia-Martinez E, Gonzalez Martin A. Efficacy and safety results from GEICO 1205, a randomized phase II trial of neoadjuvant chemotherapy with or without bevacizumab for advanced epithelial ovarian cancer. Int J Gynecol Cancer. 2019 Jul;29(6):1050-1056. doi: 10.1136/ijgc-2019-000256. PubMed PMID: 31263024.
AÑO: 2019; IF: 2.095
< AnteriorSiguiente >

Instituto de Investigación Sanitaria Acreditado

ISCII

HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL